[5] FDA, Warning Letter to Novo Nordisk, Inc
To find a qualified practitioner near you, visit: www.functionalmedicinedoctors.com Medical and Scientific References GLP-1 Physiology how GLP-1 regulates insulin secretion, appetite, and gastric emptying in humans GLP-1 Receptor Agonists and Weight Loss effectiveness for weight and glycemic control (RCT syntheses) Weight Regain After Discontinuation what happens when GLP-1 RA therapy stops GutBrain Axis and GLP-1 how gut signals drive GLP-1, satiety, and metabolic regulation Insulin Resistance and the Defended Metabolic Set-Point evidence that body weight is actively defended and linked to IR Gut Microbiome and Inflammation dysbiosis, barrier leak, and systemic inflammation in metabolic dysfunction Mitochondrial Health and Detoxification roles in energy production and resilience during weight loss -------- ATTENTION DOCTORS, ALL HEALTHCARE PRACTITIONERS, PATIENTS and POTENTIAL NEW PATIENTS If you found this article of value may I ask if you can tell your friends and colleagues about Clinical Rounds
(2025) reported no increased risk of fetal cardiac or fetal kidney anomalies
Anxiety Another side effect of weight-loss medications is increased anxiety, which may escalate to self-harming behaviors in extreme cases
This then causes the pancreas to produce more insulin to force the cells to take the sugar in
